Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clevudine vs Adefovir in HBeAg(-) Chronic Hepatitis B
NCT00641082Phase 4Completed
- Sponsor
- Bukwang Pharmaceutical
- Start
- Feb 2008
- Primary completion
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of clevudine in Chronic Hepatitis B (CHB), sponsored by Bukwang Pharmaceutical. Started Feb 2008; status: completed.
02
Drugs
clevudine
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT00641082.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00641082.